adapthealth corp. - AHCO

AHCO

Close Chg Chg %
6.49 -0.30 -4.62%

Closed Market

6.19

-0.30 (4.62%)

Volume: 2.89M

Last Updated:

Sep 8, 2026, 4:00 PM EDT

Company Overview: adapthealth corp. - AHCO

AHCO Key Data

Open

$6.48

Day Range

6.11 - 6.52

52 Week Range

5.21 - 13.43

Market Cap

$884.87M

Shares Outstanding

136.34M

Public Float

86.39M

Beta

1.39

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.68

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

3.07M

 

AHCO Performance

1 Week
 
0.00%
 
1 Month
 
14.06%
 
3 Months
 
-36.12%
 
1 Year
 
-30.14%
 
5 Years
 
-72.71%
 

AHCO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About adapthealth corp. - AHCO

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Conshohocken, PA.

AHCO At a Glance

AdaptHealth Corp.
555 East North Lane
Conshohocken, Pennsylvania 19428
Phone 1-610-424-4515 Revenue 3.24B
Industry Medical/Nursing Services Net Income -70,794,000.00
Sector Health Services Employees 10,900
Fiscal Year-end 12 / 2026
View SEC Filings

AHCO Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.415
Price to Book Ratio 0.888
Price to Cash Flow Ratio 2.24
Enterprise Value to EBITDA 4.957
Enterprise Value to Sales 0.971
Total Debt to Enterprise Value 0.604

AHCO Efficiency

Revenue/Employee 297,693.303
Income Per Employee -6,494.862
Receivables Turnover 8.749
Total Asset Turnover 0.72

AHCO Liquidity

Current Ratio 1.023
Quick Ratio 0.811
Cash Ratio 0.149

AHCO Profitability

Gross Margin 17.522
Operating Margin 6.384
Pretax Margin -0.467
Net Margin -2.182
Return on Assets -1.57
Return on Equity -4.583
Return on Total Capital -2.069
Return on Invested Capital -2.025

AHCO Capital Structure

Total Debt to Total Equity 125.303
Total Debt to Total Capital 55.615
Total Debt to Total Assets 42.836
Long-Term Debt to Equity 120.776
Long-Term Debt to Total Capital 53.606
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Adapthealth Corp. - AHCO

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
2.97B 3.20B 3.26B 3.24B
Sales Growth
+21.02% +7.73% +1.90% -0.49%
Cost of Goods Sold (COGS) incl D&A
2.62B 2.78B 2.62B 2.68B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
423.44M 420.59M 409.28M 428.38M
Depreciation
383.44M 387.99M 386.98M 408.08M
Amortization of Intangibles
40.00M 32.60M 22.30M 20.30M
COGS Growth
+26.48% +6.10% -5.50% +1.96%
Gross Income
352.54M 422.48M 636.05M 568.56M
Gross Income Growth
-8.32% +19.84% +50.55% -10.61%
Gross Profit Margin
+11.87% +13.20% +19.50% +17.52%
2022 2023 2024 2025 5-year trend
SG&A Expense
156.12M 182.03M 341.44M 361.39M
Research & Development
- - - -
-
Other SG&A
156.12M 182.03M 341.44M 361.39M
SGA Growth
+34.55% +16.60% +87.57% +5.84%
Other Operating Expense
- - - -
-
Unusual Expense
(11.15M) 851.00M 41.27M 149.90M
EBIT after Unusual Expense
207.57M (610.56M) 253.34M 57.27M
Non Operating Income/Expense
(253.00K) 18.87M 9.74M 33.33M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
109.41M 132.10M 127.07M 105.75M
Interest Expense Growth
+14.94% +20.73% -3.81% -16.77%
Gross Interest Expense
109.41M 132.10M 127.07M 105.75M
Interest Capitalized
- - - -
-
Pretax Income
97.90M (723.78M) 136.02M (15.15M)
Pretax Income Growth
-48.73% -839.29% +118.79% -111.14%
Pretax Margin
+3.30% -22.62% +4.17% -0.47%
Income Tax
24.77M (49.00M) 41.24M 50.88M
Income Tax - Current - Domestic
(197.00K) 13.59M 9.19M 3.72M
Income Tax - Current - Foreign
- - - 6.93M
-
Income Tax - Deferred - Domestic
12.21M (62.59M) 32.05M 47.16M
Income Tax - Deferred - Foreign
- - - 5.83M
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (7.67M)
-
Consolidated Net Income
73.13M (674.78M) 87.11M (66.04M)
Minority Interest Expense
3.82M 4.12M 4.36M 4.76M
Net Income
69.32M (678.89M) 82.75M (70.79M)
Net Income Growth
-55.62% -1,079.42% +112.19% -185.55%
Net Margin Growth
+2.33% -21.21% +2.54% -2.18%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
69.32M (678.89M) 82.75M (70.79M)
Preferred Dividends
- - - -
-
Net Income Available to Common
69.32M (678.89M) 82.75M (70.79M)
EPS (Basic)
0.5166 -5.0605 0.6186 -0.5238
EPS (Basic) Growth
-58.22% -1,079.58% +112.22% -184.68%
Basic Shares Outstanding
134.18M 134.16M 133.76M 135.15M
EPS (Diluted)
0.4987 -5.0605 0.6105 -0.5238
EPS (Diluted) Growth
-57.52% -1,114.74% +112.06% -185.80%
Diluted Shares Outstanding
138.99M 134.42M 135.53M 135.15M
EBITDA
619.86M 661.04M 703.89M 635.55M
EBITDA Growth
+3.02% +6.64% +6.48% -9.71%
EBITDA Margin
+20.87% +20.66% +21.59% +19.59%

Snapshot

Average Recommendation BUY Average Target Price 9.857
Number of Ratings 7 Current Quarters Estimate -0.051
FY Report Date 09 / 2026 Current Year's Estimate -0.203
Last Quarter’s Earnings 0.16 Median PE on CY Estimate N/A
Year Ago Earnings 0.619 Next Fiscal Year Estimate -0.027
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 7 4 7
Mean Estimate -0.05 -0.03 -0.20 -0.03
High Estimates 0.12 0.18 -0.10 0.68
Low Estimate -0.15 -0.12 -0.29 -0.27
Coefficient of Variance -159.91 -373.64 -41.78 -1,249.52

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 6 5
OVERWEIGHT 1 1 1
HOLD 0 0 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Overweight

Insider Actions for Adapthealth Corp. - AHCO

Date Name Shares Transaction Value
Aug 17, 2026 Dale B. Wolf Director 143,234 Open market or private purchase of non-derivative security Non-derivative transaction at $6.3 per share 902,374.20
Mar 17, 2026 Albert A. Prast Chief Technology Officer 532,358 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $4.38 per share 2,331,728.04
Mar 17, 2026 Albert A. Prast Chief Technology Officer 474,155 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $10.33 per share 4,898,021.15
Mar 17, 2026 Albert A. Prast Chief Technology Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jan 14, 2026 Ted B. Lundberg Director 873,496 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 14, 2026 Gregory A. Belinfanti Director 85,270 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Adapthealth Corp. in the News